The Illusion of Success

In the midst of a seemingly vibrant Halloween celebration in 2014, Alan Beam, the laboratory director for Theranos, faces overwhelming pressure and anxiety regarding the company’s future. While revelers enjoy the night in costumes, Beam grapples with an alarming secret: Theranos' blood-testing technology, which has captivated investors and the public alike, is fundamentally flawed. The company's need for FDA approval hangs in the balance as Beam understands the broader implications—faulty technology could lead to misdiagnoses and even harm to patients. This internal turmoil reveals the dichotomy between the public perception of success and the reality of the company’s imminent crisis.